5 Results for "

triacylglyceride

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "triacylglyceride" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-124418
CAS No.: 781628-99-7
Purity:  ≥98.0%
SBI-477 is a chemical probe that stimulates insulin signaling by deactivating the transcription factor MondoA. SBI-477 can lead to reduced expression of the insulin pathway suppressors thioredoxin-interacting protein (TXNIP) and arrestin domain-containing 4 (ARRDC4). SBI-477 coordinately inhibits triacylglyceride (TAG) synthesis and enhances basal glucose uptake in human skeletal myocytes .
loading...
    loading...
Cat. No.: HY-122682
CAS No.: 2073059-82-0
Purity:  98.67%
Target:  

Drug Derivative

Research Areas:  

Metabolic Disease

SBI-993 is a SBI-477 analog with improved potency and suitable pharmacokinetic properties for in vivo bioavailability. SBI-993 stimulates insulin signaling by deactivating the transcription factor MondoA .
loading...
    loading...
Cat. No.: HY-N2078
CAS No.: 512-06-1
Synonyms: Neodiosgenin
Yamogenin (Neodiosgenin) is a diastereomer of diosgenin. Yamogenin antagonizes the activation of the liver X receptor (LXR) in luciferase ligand assay. Yamogenin inhibits triacylglyceride (TG) accumulation through the suppression of gene expression of fatty acid synthesis in HepG2 hepatocytes. Yamogenin is a steroidal saponin that can be obtained from plant species with in vitro cytotoxicity, antioxidant, and antimicrobial properties. Yamogenin induces cell death via the extrinsic and intrinsic way of apoptosis. Yamogenin inhibits protein denaturation with an IC50 of 1421.92 μg/mL. Yamogenin can be studied in research on gastric cancer .
loading...
    loading...
Cat. No.: HY-N2078R
CAS No.: 512-06-1
Synonyms: Neodiosgenin (Standard)
Yamogenin (Standard) is the analytical standard of Yamogenin. This product is intended for research and analytical applications. Yamogenin (Neodiosgenin) is a diastereomer of diosgenin. Yamogenin antagonizes the activation of the liver X receptor (LXR) in luciferase ligand assay. Yamogenin inhibits triacylglyceride (TG) accumulation through the suppression of gene expression of fatty acid synthesis in HepG2 hepatocytes. Yamogenin is a steroidal saponin that can be obtained from plant species with in vitro cytotoxicity, antioxidant, and antimicrobial properties. Yamogenin induces cell death via the extrinsic and intrinsic way of apoptosis. Yamogenin inhibits protein denaturation with an IC50 of 1421.92 μg/mL. Yamogenin can be studied in research on gastric cancer .
loading...
    loading...
Cat. No.: HY-122904
CAS No.: 2650088-70-1
Target:  

Endogenous Metabolite

Research Areas:  

Metabolic Disease

ML377 is a selective triacylglyceride accumulation inhibitor with an IC50 of 1.1 μM .
loading...
    loading...